The Gene Therapy market size is USD 9.9 Billion in 2026.
The Gene Therapy market is projected to register a 18.3% CAGR by 2033.
The Gene Therapy market growth drivers include advancements in gene editing technologies, rising prevalence of genetic disorders and chronic diseases, and increasing investment and funding.
North America is the dominating region for the Gene Therapy market.
Amgen Inc., Novartis AG, Gilead Sciences, Inc., bluebird bio, Inc., and Merck & Co. are some leading industry players in the Gene Therapy market.
Quality assured
Buy now
Report Description
Research Methodology
